(Q67723031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Effects of long-term treatment with prazosin on left ventricular diastolic function in mild to moderate hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Effects of Long-term Treatment with Prazosin on Left Ventricular Diastolic Function in Mild to Moderate Hypertension (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

10 November 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

10 November 2022

author name string

C. Alli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

M. Di Tullio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

G. Mariotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

E. Taioli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

C. Belli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

M. Radice

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729066

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:S0012369216331452?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

https://api.elsevier.com/content/article/PII:S0012369216331452?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

10 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

181-186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Diastolic function of the heart in untreated primary hypertension

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Assessment of ventricular function in arterial hypertension with radionuclide ventriculography

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Determinants of abnormal left ventricular filling in early hypertension

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Echocardiographic studies of regression of left ventricular hypertrophy in hypertension

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Cardiac involvement in hypertension

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Left ventricular hypertrophy: its prime importance as a controllable risk factor.

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Behavioral vs beta-blocker therapy in patients with primary hypertension: effects on blood pressure, left ventricular function and mass, and the pressor surge of social stress anger

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Alterations in left ventricular filling with beta-adrenergic blockade

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Effects of intravenous verapamil administration on left ventricular diastolic function in systemic hypertension

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

The effects of antihypertensive therapy on left ventricular mass in elderly patients

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Abnormal left ventricular relaxation in hypertensive patients

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index.

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Hypertensive hypertrophic cardiomyopathy of the elderly

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Left ventricular compliance: Mechanisms and clinical implications

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Cardiac hypertrophy: the consequences for diastole

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Factors regulating myocardial hypertrophy in hypertension

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Cardiac interstitium in health and disease: the fibrillar collagen network

10 November 2022

40

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Changes in rat ventricular isomyosins with regression of cardiac hypertrophy

10 November 2022

41

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Changes in ventricular septal thickness in systemic hypertension during treatment with methyldopa and prazosin

10 November 2022

42

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans

10 November 2022

43

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?

10 November 2022

44

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?

10 November 2022

45

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

Reversal of cardiac hypertrophy in humans

10 November 2022

46

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.181

10 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729066%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference